Bacteriocin and its effect against skin pathogens
Paper Details
Bacteriocin and its effect against skin pathogens
Abstract
This paper aims to examine the isolation of Lactobacillus from dairy products (milk, curd, and yogurt), extraction of Bacteriocin from it as well as to determine their inhibitory effect against few fungal skin pathogens and bacterial skin pathogens such as: Candida albicans, Aspergillus sp., Malassezia sp., Fusarium sp., and Penicillium sp., Staphylococcus aureus, Streptococcus pyogens, Klebsiella sp. The antagonistic activity of Lactobacillus sp. is mainly due to the bacteriocin present in it, therefore in this study, the bacteriocin is extracted and checked against the indicated microorganisms. Kirby Bauer Disc Diffussion method is used and zone of clearance is observed around the pathogenic species indicating that they shows some kind of antagonistic activities which are further measured and noted, which gives a clear picture about the degree of resistance of bacteriocin against the pathogenic microorganisms.
Aasen IM, Moretro T. 2018. Extraction and Purification of Bacteriocins from Lactic Acid Bacteria. In Bacteriocins: Production, Applications and Safety (pp. 73-91). Springer.
Beveridge TJ. 2001. Use of the Gram stain in microbiology. Biotechnic & Histochemistry 76(3), 111-118.
Buchanan RE. 1982. Microbial staining methods. ASM Press.
Cotter PD, Hill C, Ross RP. 2005. Bacteriocins: Developing innate immunity for food. Nature Reviews Microbiology 3(10), 777-88. DOI: 10.1038/nrmicro1273.
Fernández L. 2019. Fighting Fire with Fire: Exploiting Bacterial Antagonism to Combat Drug Resistance. Trends in Microbiology 27(4), 168-174.
Gupta AK, Kohli Y. 2004. Prevalence of Malassezia species on various body sites in clinically healthy subjects representing different age groups. Med Mycol. 42(1), 35-42. DOI: 10.1080/13693780310001610056.
Hall GS, Dorsch MM. 2002. Skin and soft tissue infections. In Principles and Practice of Infectious Diseases (6th ed., Vol. 1, pp. 309-331). Elsevier.
Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Sanders ME. 2014. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology 11(8), 506-514. DOI: 10.1038/nrgastro.2014.66.
Kirkpatrick CH. 2001. Chronic mucocutaneous candidiasis. Pediatr Infect Dis J. 20(2), 197-206. DOI: 10.1097/00006454-200102000-00017.
Mokoena MP. 2017. Lactic acid bacteria and their bacteriocins: classification, biosynthesis and applications against uropathogens: a mini-review. Molecules 22(8), 1255.
Nucci M, Anaissie E. 2007. Fusarium infections in immunocompromised patients. Clin Microbiol Rev. 20(4), 695-704. DOI: 10.1128/CMR.00014-07.
Paterson DL, Bonomo RA. 2005. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 18(4), 657-86. DOI: 10.1128/CMR.18.4.657-686.2005.
Perez RH, Zendo T, Sonomoto K. 2014. Novel bacteriocins from lactic acid bacteria (LAB): various structures and applications. Microbial Cell Factories 13(Suppl 1), S3. DOI: 10.1186/1475-2859-13-S1-S3
Prendiville JS, Hebert AA, Greenwald MJ, Esterly NB. 1989. Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. J. Pediatr. 115(6), 881-7. DOI: 10.1016/s0022-3476(89)80736-x.
Riley MA, Wertz JE. 2002. Bacteriocins: Evolution, Ecology, and Application. Annual Review of Microbiology 56, 117-137. DOI: 10.1146/annurev.micro.56.012302.161024.
Salminen S, von Wright A, Ouwehand A. 2004. Lactic Acid Bacteria: Microbiological and Functional Aspects (4th ed.). CRC Press. https://doi.org/10.1201/b11503
Schlegel HG. 1976. General Microbiology. Cambridge University Press.
Stevens DL, Bryant AE. 2017. Necrotizing Soft-Tissue Infections. N. Engl. J. Med. 377(23), 2253-2265. DOI: 10.1056/NEJMra1600673.
Ventola CL. 2015. The antibiotic resistance crisis: part 1: causes and threats. P&T: A Peer-Reviewed Journal for Formulary Management 40(4), 277-283.
Walsh TJ, Groll AH. 1999. Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century. Transpl Infect Dis. 1(4), 247-61. DOI: 10.1034/j.1399-3062.1999.010404.x.
Aparna Ravi, M. Thankavel (2024), Bacteriocin and its effect against skin pathogens; IJMM, V18, N2, February, P1-7
https://innspub.net/bacteriocin-and-its-effect-against-skin-pathogens/
Copyright © 2024
By Authors and International
Network for Natural Sciences
(INNSPUB) https://innspub.net
This article is published under the terms of the
Creative Commons Attribution License 4.0